We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
1176
Flotek Industries
FTK
$1.28B
$166K ﹤0.01%
42,296
+679
+2% +$2.64K
OMCC
1177
DELISTED
Old Market Capital Corp
OMCC
$160K ﹤0.01%
23,487
+2,112
+10% +$12.1K
SGMO
1178
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$160K ﹤0.01%
295,000
UUU icon
1179
Universal Safety Products Inc
UUU
$10.6M
$159K ﹤0.01%
95,980
-10,620
-10% -$29.7K
ACRV icon
1180
Acrivon Therapeutics
ACRV
$74M
$157K ﹤0.01%
+31,981
New +$169K
LITS
1181
Lite Strategy Inc
LITS
$30.9M
$156K ﹤0.01%
26,869
+8,500
+46% +$56.5K
GROV icon
1182
Grove Collaborative
GROV
$46.1M
$154K ﹤0.01%
87,025
+15,000
+21% +$28.9K
TSBX
1183
DELISTED
Turnstone Biologics
TSBX
$152K ﹤0.01%
+59,900
New +$156K
SYPR icon
1184
Sypris Solutions
SYPR
$46.7M
$152K ﹤0.01%
75,204
-25,000
-25% -$48.3K
GANX icon
1185
Gain Therapeutics
GANX
$77.6M
$151K ﹤0.01%
46,100
KZR
1186
DELISTED
Kezar Life Sciences
KZR
$150K ﹤0.01%
15,860
-15,150
-49% -$133K
LUMO
1187
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$149K ﹤0.01%
47,643
CLYM
1188
Climb Bio
CLYM
$804M
$148K ﹤0.01%
55,223
OKUR
1189
OnKure Therapeutics
OKUR
$168M
$146K ﹤0.01%
9,138
WGS icon
1190
GeneDx Holdings
WGS
$2.3B
$146K ﹤0.01%
53,000
+25,000
+89% +$58.1K
QNCX icon
1191
Quince Therapeutics
QNCX
$29.5M
$145K ﹤0.01%
692
ASMB icon
1192
Assembly Biosciences
ASMB
$529M
$143K ﹤0.01%
14,500
JYNT icon
1193
The Joint Corp
JYNT
$119M
$142K ﹤0.01%
14,800
RBT
1194
DELISTED
Rubicon Technologies, Inc.
RBT
$142K ﹤0.01%
76,825
+61,325
+396% +$121K
PBHC icon
1195
Pathfinder Bancorp
PBHC
$104M
$141K ﹤0.01%
10,200
MGYR icon
1196
Magyar Bancorp
MGYR
$123M
$141K ﹤0.01%
12,579
PXLW icon
1197
Pixelworks
PXLW
$41.6M
$138K ﹤0.01%
8,792
-4,166
-32% -$60.4K
KPLT icon
1198
Katapult Holdings
KPLT
$33.2M
$136K ﹤0.01%
12,416
AWRE icon
1199
Aware
AWRE
$27.7M
$134K ﹤0.01%
80,679
VIA
1200
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$134K ﹤0.01%
14,240
-3,500
-20% -$27.5K

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.